4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide

C25H30N4O5S — CID 41209789

IUPAC4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide
SMILESCc1ccc(C(=O)NN2C(=O)N[C@](C)(CCc3ccccc3)C2=O)cc1S(=O)(=O)N1CCCCC1
InChIInChI=1S/C25H30N4O5S/c1-18-11-12-20(17-21(18)35(33,34)28-15-7-4-8-16-28)22(30)27-29-23(31)25(2,26-24(29)32)14-13-19-9-5-3-6-10-19/h3,5-6,9-12,17H,4,7-8,13-16H2,1-2H3,(H,26,32)(H,27,30)/t25-/m1/s1
InChIKeyQAYSOPJKKXUSRT-RUZDIDTESA-N
MW498.61 g/mol
LogP2.76
Rot. Bonds7

About 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide

4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide (PubChem CID 41209789) has the molecular formula C25H30N4O5S and a molecular weight of 498.61 g/mol. Its IUPAC name is 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide.

Molecular Properties

Compound Name4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide
PubChem CID41209789
Molecular FormulaC25H30N4O5S
Molecular Weight498.61 g/mol
Exact Mass498.19
IUPAC Name4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide
SMILESCc1ccc(C(=O)NN2C(=O)N[C@](C)(CCc3ccccc3)C2=O)cc1S(=O)(=O)N1CCCCC1
InChIInChI=1S/C25H30N4O5S/c1-18-11-12-20(17-21(18)35(33,34)28-15-7-4-8-16-28)22(30)27-29-23(31)25(2,26-24(29)32)14-13-19-9-5-3-6-10-19/h3,5-6,9-12,17H,4,7-8,13-16H2,1-2H3,(H,26,32)(H,27,30)/t25-/m1/s1
InChIKeyQAYSOPJKKXUSRT-RUZDIDTESA-N
XLogP2.76
TPSA115.89 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500498.61
LogP ≤ 52.76
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide?
The IUPAC name of 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide (CID 41209789) is 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide.
What is the SMILES notation for 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide?
The canonical SMILES for 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide is Cc1ccc(C(=O)NN2C(=O)N[C@](C)(CCc3ccccc3)C2=O)cc1S(=O)(=O)N1CCCCC1.
What is the InChIKey of 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide?
The InChIKey is QAYSOPJKKXUSRT-RUZDIDTESA-N. The full InChI is InChI=1S/C25H30N4O5S/c1-18-11-12-20(17-21(18)35(33,34)28-15-7-4-8-16-28)22(30)27-29-23(31)25(2,26-24(29)32)14-13-19-9-5-3-6-10-19/h3,5-6,9-12,17H,4,7-8,13-16H2,1-2H3,(H,26,32)(H,27,30)/t25-/m1/s1.
What are the key properties of 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide?
4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide has a molecular weight of 498.61 g/mol, XLogP of 2.76, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-N-[(4R)-4-methyl-2,5-dioxo-4-(2-phenylethyl)imidazolidin-1-yl]-3-piperidin-1-ylsulfonylbenzamide is sourced from PubChem (CID 41209789), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).